I think when they said "USA IMF sales are expected to be immaterial" one could say they have no great rush to move forward, that is the strategy they have communicated so why do you suddenly expect it to change. Obviously they have there reasons for the slow move and it may just be they are chasing FDA approval before they proceed, you may not like it but that is A2M.
A2M Price at posting:
$4.77 Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)